|
Volumn 348, Issue , 2014, Pages
|
Patent wars: Affordable medicines versus intellectual property rights
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
ANTIVIRUS AGENT;
GENERIC DRUG;
SOFOSBUVIR;
SORAFENIB;
TENOFOVIR;
TRASTUZUMAB;
ARTICLE;
BRAZIL;
BREAST CANCER;
CHINA;
COMMERCIAL PHENOMENA;
COST CONTROL;
DRUG APPROVAL;
DRUG COST;
DRUG INDUSTRY;
DRUG MARKETING;
DRUG RESEARCH;
FINANCIAL MANAGEMENT;
FOOD AND DRUG ADMINISTRATION;
GOVERNMENT;
HEPATITIS B;
HEPATITIS C;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INDIA;
INTERNATIONAL COOPERATION;
LAW;
LICENCE;
PATENT;
PHILIPPINES;
PRIORITY JOURNAL;
SOUTH AFRICA;
THAILAND;
UNITED STATES;
DRUG INDUSTRY;
HUMAN RIGHTS;
HUMANS;
INTELLECTUAL PROPERTY;
LEGISLATION, DRUG;
PHARMACEUTICAL PREPARATIONS;
PUBLIC HEALTH;
|
EID: 84896716475
PISSN: None
EISSN: 17561833
Source Type: Journal
DOI: 10.1136/bmj.g1533 Document Type: Article |
Times cited : (4)
|
References (12)
|